Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2013-04-23

Clinical Trial Update: Epiphrenic III Pilot Trial [NA]

View source ↗

Summary

Clinical trial update for Epiphrenic III Pilot Trial sponsored by Luzerner Kantonsspital, related to heart failure; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Luzerner Kantonsspital | Conditions: Heart Failure | NA | Status: UNKNOWN